Skip to main content
An official website of the United States government

DNA interference oligonucleotide PNT2258

A liposomal formulation of the 24-mer oligonucleotide PNT100, with potential antineoplastic activity. PNT2258 targets and complements to untranscribed DNA sequence upstream of BCL2 promoters, thereby interfering with DNA replication and transcription of the BCL2 gene. This may promote and restore the apoptotic pathway in BCL2-overexpressing tumor cells. BCL2, an anti-apoptotic protein, is overexpressed in a wide variety of tumors.
Synonym:DNA interference drug PNT2258
US brand name:DNAi® drug PNT2258
Code name:PNT2258
Search NCI's Drug Dictionary